A radioimmunoassay for parathymosin

Area of Science:

• Immunology
• Biochemistry
• Molecular Biology

Background:

• Parathymosin is structurally related to prothymosin alpha.
• Prothymosin alpha has known immunoenhancing effects in vivo.
• Parathymosin has been shown to inhibit these immunoenhancing effects.

Purpose of the Study:

• To develop a sensitive method for quantifying parathymosin.
• To determine the tissue and fluid distribution of parathymosin.
• To understand the role of parathymosin in biological systems.

Main Methods:

• Development of a radioimmunoassay (RIA) using rabbit antiserum against rat liver parathymosin.
• Testing for cross-reactivity with thymosin alpha 1 and prothymosin alpha.
• Characterization of the major epitope using peptide fragments.
• Quantification of parathymosin in various rat tissues and human blood components.

Main Results:

• The RIA demonstrated high specificity for parathymosin, with no significant cross-reactivity with prothymosin alpha or thymosin alpha 1.
• The major epitope recognized by the antiserum is located within residues 26-32 of parathymosin.
• Highest parathymosin concentrations were found in rat liver and kidney (230-240 µg/g), followed by brain, lung, thymus, and spleen.
• Human leukocytes contain 2-3 pmol/ml of parathymosin, which is approximately one-fifth the amount of prothymosin alpha.
• Parathymosin was undetectable in human plasma.

Conclusions:

• A specific and sensitive radioimmunoassay for parathymosin has been successfully developed.
• Parathymosin is widely distributed in rat tissues, with the highest concentrations in the liver and kidney.
• The distribution and levels of parathymosin in human leukocytes suggest a potential role in immune cell function.
• Further research is warranted to elucidate the precise biological functions of parathymosin.